You are here

Dynavax

Dynavax and US Department of Defense collaborate on adjuvanted plague vaccine development

Dynavax and US Department of Defense collaborate on adjuvanted plague vaccine development

Biopharma Reporter

Department of Defense

clinical trials

pneumonic plague

Flag link:

Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine

Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine

Fierce Pharma

drug manufacturing

Flag link:

The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says

The first round of Covid-19 vaccines is ‘highly unlikely to be a magic bullet,’ Medicago CEO says

Stat

Flag link:

Using GSK and Dynavax tech, Clover kick-starts COVID-19 vax trial with data drop in August

Using GSK and Dynavax tech, Clover kick-starts COVID-19 vax trial with data drop in August

Fierce Biotech

Clover BioPharmaceuticals

Flag link:

Asthma Drug Co-Developed by Dynavax and AstraZeneca Fails to Meet Endpoints in Phase IIa Trial

Asthma Drug Co-Developed by Dynavax and AstraZeneca Fails to Meet Endpoints in Phase IIa Trial

BioSpace

clinical trials

Flag link:

Watch These Biotechs and the FDA Calendar

Watch These Biotechs and the FDA Calendar

TheStreet.com

Flag link:

Watch These February Biotech Catalysts

Watch These February Biotech Catalysts

Seeking Alpha

Puma Biotechnology

Flag link:

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

TheStreet.com

Synergy Pharmaceuticals

BioDelivery Sciences

Heron Therapeutics

Flag link:

Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up

Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up

Reuters

Flag link:

Dynavax shares dip after FDA asks for more time to sort out Heplisav post-marketing plan

Dynavax shares dip after FDA asks for more time to sort out Heplisav post-marketing plan

Endpoints

Flag link:

Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel

Data supports safety of Dynavax hepatitis B vaccine -U.S. FDA panel

Yahoo/Reuters

advisory panels

Flag link:

Dynavax shares slide as FDA review spotlights a hazy safety issue for Heplisav

Dynavax shares slide as FDA review spotlights a hazy safety issue for Heplisav

Endpoints

Flag link:

5 Biotech Stocks With Major Catalysts in July

5 Biotech Stocks With Major Catalysts in July

Motley Fool

Puma Biotechnology

Flag link:

Dynavax's stock plunges after disappointing FDA response to Hep-B treatment

Dynavax's stock plunges after disappointing FDA response to Hep-B treatment

Marketwatch

Flag link:

What Will Dynavax Do if Heplisav-B Is Rejected?

What Will Dynavax Do if Heplisav-B Is Rejected?

Motley Fool

Flag link:

FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk

FDA Precedent Suggests Dynavax Hep B Vaccine Faces High Rejection Risk

TheStreet.com

Flag link:

5 Small-Cap Biotechs With Big Potential

5 Small-Cap Biotechs With Big Potential

TheStreet.com

Portola Pharmaceuticals

Redhill Biopharma

Amicus Therapeutics

Flag link:

Dynavax, GlaxoSmithKline Battling In Same Industry: Who Will Win?

Dynavax, GlaxoSmithKline Battling In Same Industry: Who Will Win?

Yahoo/Benzinga

Flag link:

3 Scorned Biotechs Destined to Rebound

3 Scorned Biotechs Destined to Rebound

TheStreet.com

Merrimack Pharmaceuticals

Flag link:

2 Attractive Small Biotech Stocks That Could Become Buyout Targets

2 Attractive Small Biotech Stocks That Could Become Buyout Targets

Seeking Alpha

Conatus Pharmaceuticals

Gilead Sciences

Flag link:

Pages